UCB Stock CINNOBER BOAT
Stocks
0NZT
BE0003739530
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.25 EUR | 0.00% |
|
0.00% | - |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 06-22 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
| Market Cap | 49.87B 56.98B 46.04B 42.95B 80.92B 5,388B 82.36B 552B 214B 2,659B 214B 209B 9,262B | P/E 2026 * |
28.3x | P/E 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 48.95B 55.92B 45.19B 42.15B 79.42B 5,288B 80.84B 542B 210B 2,609B 210B 205B 9,090B | EV / Sales 2026 * |
5.74x | EV / Sales 2027 * | 4.88x |
| Free-Float |
61.59% | Yield 2026 * |
0.56% | Yield 2027 * | 0.57% |
Last Transcript: UCB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 57.29B | |
| -1.30% | +1.10% | +19.01% | -13.05% | 64.28B | |
| -3.94% | +39.10% | +39.10% | +39.10% | 43.45B | |
| -0.56% | +1.65% | -51.04% | -58.77% | 38.02B | |
| +0.23% | +10.25% | +73.10% | -23.68% | 31.98B | |
| +0.67% | +15.31% | +154.95% | -42.11% | 27.66B | |
| -0.20% | +9.88% | +68.44% | +84.27% | 22.91B | |
| -0.56% | +5.64% | +2.91% | +174.96% | 17.74B | |
| -0.13% | -0.94% | +60.31% | +119.58% | 16.45B | |
| +2.35% | +7.53% | +70.91% | +329.07% | 14.1B | |
| Average | -0.38% | +6.92% | +48.63% | +67.71% | 30.73B | |
| Weighted average by Cap. | -0.74% | +6.00% | +40.55% | +30.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.75B 7.88B 7.35B 13.85B 922B 14.09B 94.49B 36.68B 455B 36.63B 35.81B 1,585B | 9.63B 11B 8.89B 8.29B 15.62B 1,040B 15.9B 107B 41.38B 513B 41.32B 40.4B 1,788B |
| Net income | 1.75B 2B 1.61B 1.5B 2.83B 189B 2.88B 19.34B 7.51B 93.1B 7.5B 7.33B 324B | 2.29B 2.61B 2.11B 1.97B 3.71B 247B 3.78B 25.32B 9.83B 122B 9.81B 9.59B 425B |
| Net Debt | -925M -1.06B -854M -797M -1.5B -99.93B -1.53B -10.24B -3.98B -49.31B -3.97B -3.88B -172B | -2.93B -3.35B -2.71B -2.52B -4.76B -317B -4.84B -32.47B -12.61B -156B -12.59B -12.3B -545B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- UCB Stock
- 0NZT Stock
Select your edition
All financial news and data tailored to specific country editions
